[CLINICAL EXPERIENCES WITH AN OVULATION-SUPPRESSING ESTROGEN-GESTAGEN COMBINATION (ANOVLAR)].
D004338:Drug Combinations; D004358:Drug Therapy; D004412:Dysmenorrhea; D004715:Endometriosis; D004967:Estrogens; D004997:Ethinyl Estradiol; D005260:Female; D006801:Humans; D007246:Infertility; D007247:Infertility, Female; D009640:Norethindrone; D034445:Ovulation Inhibition; D011372:Progestins
D004338:Drug Combinations; D004967:Estrogens; D011372:Progestins; C020416:norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination; D004997:Ethinyl Estradiol; D009640:Norethindrone
DRUG THERAPY; DYSMENORRHEA; ENDOMETRIOSIS; ETHINYL ESTRADIOL; NORETHINDRONE; STERILITY, FEMALE
KLINISCHE ERFAHRUNGEN MIT EINER OVULATIONS-UNTERDRUECKENDEN OSTROGEN-GESTAGEN-KOMBINATION (ANOVLAR)